Oct-3/4 is a dose-dependent oncogenic fate determinant

Sharon Gidekel, Galina Pizov, Yehudit Bergman*, Eli Pikarsky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

405 Scopus citations

Fingerprint

Dive into the research topics of 'Oct-3/4 is a dose-dependent oncogenic fate determinant'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry